|
Rose-Hellekant, T A; Schroeder, M D; Brockman, J L et al. (2007) Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss. Oncogene 26:5238-46
|
|
Rose-Hellekant, Teresa A; Wentworth, Kristin M; Nikolai, Sarah et al. (2006) Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice. Am J Pathol 169:1821-32
|
|
Rose-Hellekant, Teresa A; Arendt, Lisa M; Schroeder, Matthew D et al. (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22:4664-74
|
|
Rosner, Andrea; Miyoshi, Keiko; Landesman-Bollag, Esther et al. (2002) Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 161:1087-97
|
|
Rose-Hellekant, Teresa A; Gilchrist, Kennedy; Sandgren, Eric P (2002) Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. Am J Pathol 161:1439-47
|
|
Moser, A R; Hegge, L F; Cardiff, R D (2001) Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. Cancer Res 61:3480-5
|
|
Schroeder, M D; Rose-Hellekant, T A; Sandgren, E P et al. (2001) Dysregulation of mammary Stats 1,3 and 5 and PRL receptors by overexpression of TGFalpha. Mol Cell Endocrinol 175:173-83
|
|
Rose-Hellekant, T A; Sandgren, E P (2000) Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice. Oncogene 19:1092-6
|
|
Kohlhepp, R L; Hegge, L F; Nett, J E et al. (2000) ROSA26 mice carry a modifier of Min-induced mammary and intestinal tumor development. Mamm Genome 11:1058-62
|
|
Kisseberth, W C; Brettingen, N T; Lohse, J K et al. (1999) Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 214:128-38
|
